Prospectively validated augmented intelligence for disease-agnostic predictions of clinical success for novel therapeutics
View ORCID ProfileBragi Lovetrue, Idonae Lovetrue
doi: https://doi.org/10.1101/2022.03.14.22272372
Bragi Lovetrue
1Demiurge Technologies AG, Baarerstrasse 14 6300 Zug Switzerland
Idonae Lovetrue
1Demiurge Technologies AG, Baarerstrasse 14 6300 Zug Switzerland

- Supplemental Tables[supplements/272372_file03.xlsx]
Posted April 11, 2022.
Prospectively validated augmented intelligence for disease-agnostic predictions of clinical success for novel therapeutics
Bragi Lovetrue, Idonae Lovetrue
medRxiv 2022.03.14.22272372; doi: https://doi.org/10.1101/2022.03.14.22272372
Subject Area
Subject Areas
- Addiction Medicine (271)
- Allergy and Immunology (557)
- Anesthesia (135)
- Cardiovascular Medicine (1769)
- Dermatology (173)
- Emergency Medicine (316)
- Epidemiology (10812)
- Gastroenterology (594)
- Genetic and Genomic Medicine (2960)
- Geriatric Medicine (288)
- Health Economics (534)
- Health Informatics (1933)
- Health Policy (836)
- Hematology (293)
- HIV/AIDS (633)
- Medical Education (300)
- Medical Ethics (87)
- Nephrology (324)
- Neurology (2809)
- Nursing (152)
- Nutrition (433)
- Oncology (1473)
- Ophthalmology (444)
- Orthopedics (172)
- Otolaryngology (257)
- Pain Medicine (190)
- Palliative Medicine (56)
- Pathology (381)
- Pediatrics (868)
- Primary Care Research (338)
- Public and Global Health (5383)
- Radiology and Imaging (1016)
- Respiratory Medicine (727)
- Rheumatology (330)
- Sports Medicine (279)
- Surgery (327)
- Toxicology (48)
- Transplantation (150)
- Urology (126)